Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens.
Hae-Young ParkJin Won KwonHye-Lin KimSun-Hong KwonJin Hyun NamSerim MinIn Sun OhSungho BeaSun Ha ChoiPublished in: Journal of Korean medical science (2023)
This study confirmed that the new all-oral longer regimens for the treatment of MDR-TB were cost-effective in replacing conventional injectable-containing regimens.